Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05206422 · ClinicalTrials.gov registry record · NA
DORAYA-HF Early Feasibility Study
A NA study of Acute Decompensated Heart Failure, sponsored by Revamp Medical.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 14
- Study locations
NCT05206422: Active NA study of Acute Decompensated Heart Failure, sponsored by Revamp Medical.
NCT05206422 is a NA study of Acute Decompensated Heart Failure that is active but no longer recruiting, run by Revamp Medical. The registered enrollment target is 30 participants, below the 457-participant average among 12 other Acute Decompensated Heart Failure trials with a reported enrollment target (93% lower). The trial reports 14 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05206422, a NA study of Acute Decompensated Heart Failure, is active but no longer recruiting, sponsored by Revamp Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 14
- Study locations
Study Summary
The study objective is to evaluate the feasibility of the Doraya Catheter and measure clinical performance and safety endpoints, in ADHF patients deemed to have insufficient diuretic response.
Primary Outcome
Device or procedure related SAEs rate (including MACE) based on CEC adjudication.
Conditions Studied
Interventions
- DEVICE Doraya Catheter
Study Locations (14)
California
- Zuckerberg San Francisco General - San Francisco
- San Francisco VA - San Francisco
- UCSF - San Francisco
Ohio
- The Christ Hospital - Cincinnati
- The MetroHealth System - Cleveland
- The Ohio State University - Columbus
Georgia
- Piedmont Hospital - Augusta
- Northeast Georgia Medical Center - Gainesville
Texas
- Baylor University Medical Center - Dallas
- CHI St. Luke's Health-Baylor St. Luke's Medical Center - Houston
Florida
- Cleveland Clinic - Weston
Missouri
- Christian Hospital - St Louis
Oklahoma
- Oklahoma Heart - Oklahoma City
South Carolina
- Prisma Health - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-10-05 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT05206422 still lists
NCT05206422 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 457-participant average among 12 other Acute Decompensated Heart Failure trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Acute Decompensated Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Doraya Catheter is the first listed.
NCT05206422 lists 14 locations in 8 states (California, Ohio, Georgia).
Frequently Asked Questions
What is clinical trial NCT05206422 about?
NCT05206422 is a clinical study titled "DORAYA-HF Early Feasibility Study". The study objective is to evaluate the feasibility of the Doraya Catheter and measure clinical performance and safety endpoints, in ADHF patients deemed to have insufficient diuretic response.
What is the current status of trial NCT05206422?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-10-05. Estimated completion is 2026-03-31.
What conditions does trial NCT05206422 study?
This clinical trial studies the following conditions: Acute Decompensated Heart Failure.
What interventions are being tested in trial NCT05206422?
The interventions under investigation include: Doraya Catheter (DEVICE).
Who is sponsoring clinical trial NCT05206422?
This trial is sponsored by Revamp Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05206422 being conducted?
This trial has 14 study locations across California, Florida, Georgia, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Decompensated Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05206422's enrollment target sits among peer trials
30 10th of 12 higher than 3 of 12 other Acute Decompensated Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Decompensated Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Low Level Tragus Stimulation in Acute Decompensated Heart Failure
RECRUITING · NA
-
Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study
ACTIVE NOT RECRUITING · NA
-
RAAS Optimization for Acute CHF Patients
COMPLETED · NA
-
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)
COMPLETED · NA
-
Evaluation of Cardiopulmonary Diseases by Ultrasound
COMPLETED · NA
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI